These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6316182)

  • 1. [Side-effects of phenytoin and carbamazepine on electrophysiologic functions of the peripheral and central nervous system].
    Danner R
    Nervenarzt; 1983 Oct; 54(10):530-4. PubMed ID: 6316182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of anticonvulsants on the peripheral nervous system and vestibulo-ocular functions].
    Stefan H
    Fortschr Neurol Psychiatr; 1985 Jan; 53(1):29-32. PubMed ID: 3918921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and sensory conduction velocities and electromyographic findings in man before and after carbamazepine treatment.
    Lühdorf K; Nielsen CJ; Orbaek K; Hammerberg PE
    Acta Neurol Scand; 1983 Feb; 67(2):103-7. PubMed ID: 6845974
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
    Eisen AA; Woods JF; Sherwin AL
    Neurology; 1974 May; 24(5):411-7. PubMed ID: 4363815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].
    Bayer A; Thiel HJ; Zrenner E; Paulus W; Ried S; Schmidt D
    Nervenarzt; 1995 Feb; 66(2):89-96. PubMed ID: 7715759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydantoin poisoning: clinical aspects, laboratory parameters and EEG].
    Körner E; Ladurner G; Enge S; Lechner H
    Nervenarzt; 1983 Oct; 54(10):548-52. PubMed ID: 6646292
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Teratogenic hazards in antiepileptic therapy].
    Loiseau P; Henry TP
    Nouv Presse Med; 1974 Jan; 3(2):92. PubMed ID: 4815439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carbamazepine versus phenytoin in psychomotor epilepsy. A double-blind study of antiepileptic effect and side-effects].
    Simonsen N; Olsen PZ; Kühl V; Lund M; Wendelboe J
    Ugeskr Laeger; 1975 Oct; 137(41):2392-6. PubMed ID: 1101498
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carbamazepine in affective psychoses].
    Wunderlich HP
    Z Arztl Fortbild (Jena); 1992; Suppl 2():3-12. PubMed ID: 1340654
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of phenytoin and carbamazepine in treatment of epilepsy.
    Ramsay RE
    Neurol Clin; 1986 Aug; 4(3):585-600. PubMed ID: 2943977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.
    Gallassi R; Morreale A; Lorusso S; Procaccianti G; Lugaresi E; Baruzzi A
    Arch Neurol; 1988 Aug; 45(8):892-4. PubMed ID: 3395263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Your CE topic this month (No. 20). Antiepileptic pharmacotherapy.
    Lackner TE
    J Pract Nurs; 1986 Dec; 36(5):44-51. PubMed ID: 3643277
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsedative regimens in the treatment of epilepsy.
    Porter RJ; Theodore WH
    Arch Intern Med; 1983 May; 143(5):945-7. PubMed ID: 6433827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of combination of valproic acid with diphenylhydantoin and carbamazepine in the management of intractable seizures.
    Ashok PP; Maheshwari MC
    J Assoc Physicians India; 1984 Jul; 32(7):565-7. PubMed ID: 6438054
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of antiepileptic drugs in pregnancy in a Jordanian army hospital.
    Barqawi R
    East Mediterr Health J; 2005 Jul; 11(4):601-5. PubMed ID: 16700374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective neurometric studies during the beginning of carbamazepine and phenytoin therapy.
    Danner R; Lang H; Yale C
    Acta Neurol Scand; 1984 Apr; 69(4):207-17. PubMed ID: 6741455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.